An interpretable mortality prediction model for COVID-19 patients

World Health Organization. Coronavirus Disease 2019 (COVID-19) Situation Report 46, 6 March 2020 (2020); https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200306-sitrep-46-covid-19.pdf

World Health Organization. Coronavirus Disease 2019 (COVID-19) Situation Report 68, 28 March 2020 (2020); https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200328-sitrep-68-covid-19.pdf

Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506 (2020).

Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507–513 (2020).

Novel Coronavirus Pneumonia Emergency Response Epidemiology Team The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi 41, 145–151 (2020).

Yang, X. et al. Clinical course and outcomes of critically ill patients with SARS CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Resp. Med. 8, 475–481 (2020).

Diagnosis and Treatment of Pneumonia Infected by the New Novel Coronavirus (the trial fifth edition) Medical Letter from the National Health Office (National Health Commission of the People’s Republic of China, 2020).

Chen, T. & Guestrin, C. XGBoost: a scalable tree boosting system. In Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining 785–794 (ACM, 2016).

Lundberg, S. et al. From local explanations to global understanding with explainable AI for trees. Nat. Mach. Intell. 2, 56–67 (2020).

Truog, R. D., Mitchell, C. & Dalley, G. Q. The toughest triage—allocating ventilators in a pandemic. N. Engl. J. Med. https://doi.org/10.1056/NEJMp2005689 (2020).

Kishaba, T., Tamaki, H., Shimaoka, Y., Fukuyama, H. & Yamashiro, S. Staging of acute exacerbation in patients with idiopathic pulmonary fibrosis. Lung 192, 141–149 (2014).

Ridker, P. M. et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 359, 2195–2207 (2008).

Sharma, S. K. et al. Aetiology, outcomes & predictors of mortality in acute respiratory distress syndrome from a tertiary care centre in North India. Indian J. Med. Res. 143, 782–792 (2016).

Bajwa, E. K. et al. Plasma C-reactive protein levels are associated with improved outcome in ARDS. Chest 136, 471–480 (2009).

Liu, X. et al. A general report on the systematic anatomy of COVID-19. J. Forensic Med. 36, 1–3 (2020).

Wang, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323, 1061–1069 (2020).

Chan, J. F. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395, 514–523 (2020).

Li, F., Li, W., Farzan, M. & Harrison, S. C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309, 1864–1868 (2005).

Ge, X. Y. et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 503, 535–538 (2013).

Xu, Z. et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Resp. Med. 8, 420–422 (2020).

Liu, J. et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EbioMedicine 55, 102763 (2020).